Evidence map›Paper›PMID 31892146›Full record

ReviewMolecules (Basel, Switzerland)2019

Oxoisoaporphines and Aporphines: Versatile Molecules with Anticancer Effects.

Esteban Rodríguez-Arce, Patricio Cancino, Manuel Arias-Calderón, Paul Silva-Matus, Marianela Saldías

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.5field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Esteban Rodríguez-ArceInstituto de Investigación e Innovación en Salud, Facultad de Ciencias de la Salud, Universidad Central de Chile, Santiago 8370178, Chile.ORCID 0000-0003-0237-1852
Patricio CancinoFacultad de Ciencias Químicas y Farmacéuticas, Universidad de Chile, Santiago 8380544, Chile.ORCID 0000-0001-9767-2871
Manuel Arias-CalderónDepartamento de Ciencias Biológicas, Facultad de Ciencias de la Vida, Universidad Andres Bello, Santiago 8370146, Chile.ORCID 0000-0003-4551-3347
Paul Silva-MatusDepartamento de Ciencias de la Salud, Universidad de Aysén, Coyhaique 5951537, Chile.
Marianela SaldíasInstituto de Investigación e Innovación en Salud, Facultad de Ciencias de la Salud, Universidad Central de Chile, Santiago 8370178, Chile.ORCID 0000-0002-5036-0392
Universidad Central de Chile · CLUniversidad Andrés Bello · CLUniversidad de Aysén · CLUniversity of Chile · CL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer is a disease that involves impaired genome stability with a high mortality index globally. Since its discovery, many have searched for effective treatment, assessing different molecules for their anticancer activity. One of the most studied sources for anticancer therapy is natural compounds and their derivates, like alkaloids, which are organic molecules containing nitrogen atoms in their structure. Among them, oxoisoaporphine and sampangine compounds are receiving increased attention due to their potential anticancer effects. Boldine has also been tested as an anticancer molecule. Boldine is the primary alkaloid extract from boldo, an endemic tree in Chile. These compounds and their derivatives have unique structural properties that potentially have an anticancer mechanism. Different studies showed that this molecule can target cancer cells through several mechanisms, including reactive oxygen species generation, DNA binding, and telomerase enzyme inhibition. In this review, we summarize the state-of-art research related to oxoisoaporphine, sampangine, and boldine, with emphasis on their structural characteristics and the relationship between structure, activity, methods of extraction or synthesis, and anticancer mechanism. With an effective cancer therapy still lacking, these three compounds are good candidates for new anticancer research.

Indexed as

AlkaloidsAntineoplastic Agents, PhytogenicAporphinesEnzyme InhibitorsHeterocyclic Compounds, 4 or More RingsNaphthyridinesAnimalsHumansNeoplasm ProteinsNeoplasmsTelomeraseAlkaloidsAntineoplastic Agents, PhytogenicAporphinesboldineEnzyme InhibitorsHeterocyclic Compounds, 4 or More RingsNaphthyridinesNeoplasm ProteinssampangineTelomerasealkaloidsanticancer actionaporphineboldineoxoisoaporphineROSsampanginestructure–biological activitytelomerase inhibition

Identifiers

PMID31892146
PMCPMC6983244
OpenAlexW2998011693

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.